vs
Side-by-side financial comparison of Elastic N.V. (ESTC) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $423.5M, roughly 1.2× Elastic N.V.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -12.1%, a 18.9% gap on every dollar of revenue. On growth, Elastic N.V. posted the faster year-over-year revenue change (15.9% vs -1.7%). Over the past eight quarters, Elastic N.V.'s revenue compounded faster (13.6% CAGR vs -0.1%).
Elastic is a Dutch-American software company that provides a platform for enterprise search, observability, and cybersecurity. Its product enables users to search and analyze large-scale data, monitor system performance, and detect anomalies. Originally known as Elasticsearch, the company was founded in 2012 in Amsterdam, Netherlands, and has maintained its operational headquarters in both the Netherlands and San Francisco, California, US. Elastic is publicly traded on the New York Stock Exch...
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ESTC vs MD — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $423.5M | $493.8M |
| Net Profit | $-51.3M | $33.7M |
| Gross Margin | 75.9% | — |
| Operating Margin | -1.9% | 9.9% |
| Net Margin | -12.1% | 6.8% |
| Revenue YoY | 15.9% | -1.7% |
| Net Profit YoY | -101.5% | 10.5% |
| EPS (diluted) | $-0.48 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $423.5M | $493.8M | ||
| Q3 25 | $415.3M | $492.9M | ||
| Q2 25 | $388.4M | $468.8M | ||
| Q1 25 | $382.1M | $458.4M | ||
| Q4 24 | $365.4M | $502.4M | ||
| Q3 24 | $347.4M | $511.2M | ||
| Q2 24 | $335.0M | $504.3M | ||
| Q1 24 | $328.0M | $495.1M |
| Q4 25 | $-51.3M | $33.7M | ||
| Q3 25 | $-24.6M | $71.7M | ||
| Q2 25 | $-16.4M | $39.3M | ||
| Q1 25 | $-17.1M | $20.7M | ||
| Q4 24 | $-25.4M | $30.5M | ||
| Q3 24 | $-49.2M | $19.4M | ||
| Q2 24 | $-41.1M | $-153.0M | ||
| Q1 24 | $176.1M | $4.0M |
| Q4 25 | 75.9% | — | ||
| Q3 25 | 76.7% | — | ||
| Q2 25 | 74.8% | — | ||
| Q1 25 | 74.6% | — | ||
| Q4 24 | 74.5% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 73.8% | — | ||
| Q1 24 | 74.2% | — |
| Q4 25 | -1.9% | 9.9% | ||
| Q3 25 | -2.3% | 13.8% | ||
| Q2 25 | -3.1% | 12.8% | ||
| Q1 25 | -1.2% | 7.0% | ||
| Q4 24 | -1.2% | 7.8% | ||
| Q3 24 | -9.7% | 6.6% | ||
| Q2 24 | -13.6% | -31.3% | ||
| Q1 24 | -8.1% | 3.2% |
| Q4 25 | -12.1% | 6.8% | ||
| Q3 25 | -5.9% | 14.5% | ||
| Q2 25 | -4.2% | 8.4% | ||
| Q1 25 | -4.5% | 4.5% | ||
| Q4 24 | -7.0% | 6.1% | ||
| Q3 24 | -14.2% | 3.8% | ||
| Q2 24 | -12.3% | -30.3% | ||
| Q1 24 | 53.7% | 0.8% |
| Q4 25 | $-0.48 | $0.40 | ||
| Q3 25 | $-0.23 | $0.84 | ||
| Q2 25 | $-0.15 | $0.46 | ||
| Q1 25 | $-0.16 | $0.24 | ||
| Q4 24 | $-0.25 | $0.37 | ||
| Q3 24 | $-0.48 | $0.23 | ||
| Q2 24 | $-0.35 | $-1.84 | ||
| Q1 24 | $1.69 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $375.2M |
| Total DebtLower is stronger | $570.3M | $570.5M |
| Stockholders' EquityBook value | $891.1M | $865.9M |
| Total Assets | $2.5B | $2.2B |
| Debt / EquityLower = less leverage | 0.64× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $375.2M | ||
| Q3 25 | $1.5B | $340.1M | ||
| Q2 25 | $1.4B | $224.7M | ||
| Q1 25 | $584.0M | $99.0M | ||
| Q4 24 | $658.5M | $229.9M | ||
| Q3 24 | $594.9M | $103.8M | ||
| Q2 24 | $1.1B | $19.4M | ||
| Q1 24 | $526.9M | $8.0M |
| Q4 25 | $570.3M | $570.5M | ||
| Q3 25 | $570.0M | $577.2M | ||
| Q2 25 | $569.7M | $583.9M | ||
| Q1 25 | $569.4M | $590.5M | ||
| Q4 24 | $569.2M | $597.1M | ||
| Q3 24 | $568.9M | — | ||
| Q2 24 | $568.6M | — | ||
| Q1 24 | $568.3M | — |
| Q4 25 | $891.1M | $865.9M | ||
| Q3 25 | $971.4M | $890.7M | ||
| Q2 25 | $927.2M | $833.8M | ||
| Q1 25 | $859.1M | $789.2M | ||
| Q4 24 | $811.5M | $764.9M | ||
| Q3 24 | $759.4M | $732.5M | ||
| Q2 24 | $738.2M | $706.5M | ||
| Q1 24 | $707.8M | $856.2M |
| Q4 25 | $2.5B | $2.2B | ||
| Q3 25 | $2.5B | $2.2B | ||
| Q2 25 | $2.6B | $2.1B | ||
| Q1 25 | $2.3B | $2.0B | ||
| Q4 24 | $2.2B | $2.2B | ||
| Q3 24 | $2.2B | $2.1B | ||
| Q2 24 | $2.2B | $2.0B | ||
| Q1 24 | $2.1B | $2.2B |
| Q4 25 | 0.64× | 0.66× | ||
| Q3 25 | 0.59× | 0.65× | ||
| Q2 25 | 0.61× | 0.70× | ||
| Q1 25 | 0.66× | 0.75× | ||
| Q4 24 | 0.70× | 0.78× | ||
| Q3 24 | 0.75× | — | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 0.80× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.6M | $114.1M |
| Free Cash FlowOCF − Capex | $26.0M | — |
| FCF MarginFCF / Revenue | 6.1% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $302.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.6M | $114.1M | ||
| Q3 25 | $104.8M | $137.3M | ||
| Q2 25 | $87.0M | $137.2M | ||
| Q1 25 | $88.1M | $-117.5M | ||
| Q4 24 | $38.4M | $133.0M | ||
| Q3 24 | $52.8M | $91.8M | ||
| Q2 24 | $60.9M | $107.0M | ||
| Q1 24 | $52.4M | $-125.2M |
| Q4 25 | $26.0M | — | ||
| Q3 25 | $104.2M | — | ||
| Q2 25 | $84.9M | — | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $37.7M | — | ||
| Q3 24 | $52.0M | — | ||
| Q2 24 | $60.1M | — | ||
| Q1 24 | $51.3M | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 25.1% | — | ||
| Q2 25 | 21.8% | — | ||
| Q1 25 | 22.8% | — | ||
| Q4 24 | 10.3% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 15.6% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.30× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESTC
| Self Managed Subscription | $192.0M | 45% |
| Saa S Self Managed Annual | $156.9M | 37% |
| Saa S Self Managed Monthly | $48.8M | 12% |
| Professional Services | $25.8M | 6% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
